Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Promotion Highlights
1
Up to 50% OFF on iPSC knockout, knock-in, point mutation, overexpression, and interference models
2
Exclusively for new customers in academia and industry
3
One discounted project per customer. If ordering multiple constructs, the highest-value model receives the discount.
4
Strictly limited to the first 100 eligible projects globally!
Technical Advantages

With over a decade of expertise in cell model development, Cyagen delivers custom iPSC lines that meet the highest standards of precision, reproducibility, and scalability.

Non-integrating Reprogramming
Achieve a 99% success rate using episomal vectors.
High-Precision Gene Editing
Benefit from up to 50% HDR efficiency.
Validated Differentiation
Our iPSCs can be successfully differentiated into neurons, blood cells, RPE, and more.
Comprehensive QC
We ensure quality with sequencing, immunofluorescence, and karyotyping.
Promotional Pricing & Workflow
Service Type Standard Price Promotion Price Deliverables QC Measures
iPSC Knockout (KO) $12,800 $6,400 1 homozygous clone + WT, 2 vials/cell (1×10⁶ cells/vial) PCR, sequencing, immunofluorescence (IF), mycoplasma, and sterility testing
Point Mutation $19,200 $9,600
Knock-in (<3 kb) $19,200 $9,600 1 heterzygous clone + WT, 2 vials/cell (1×10⁶ cells/vial)
Overexpression (cell pool) $6,800 $3,400 2 vials OE pool + 2 vials control pool (1×10⁶ cells/vial)
Interference (3+1, cell pool) $12,000 $6,000 2 vials KD pool + 2 vials control pool (1×10⁶ cells/vial)
*All projects include detailed QC reports and cryopreserved vials for long-term use.
From Somatic Cells to Functional Cell Types Standard Workflow Overview
Stage Description Timeframe
Cell Expansion & QC Mycoplasma/sterility testing, primer design 1–2 weeks
Guide/Donor Design Design & synthesis of targeting guidance molecule and donor templates 2–6 weeks
Electroporation & Clone Selection Genome editing + single-cell clone screening 4–8 weeks
Final QC & Cryopreservation Genotyping, viability, IF validation 1–2 weeks
View Full Workflow Details >>
Who’s Eligible?
Customers located in North America, Europe, or Asia-Pacific
New to Cyagen’s cell line services (even if you’ve partnered with us for animal models)
Not sure if you qualify? Contact us! We're happy to help confirm your eligibility.
Offer Period
August 1 – October 31, 2025
Don't miss out! With only 100 eligible projects available, early application is strongly encouraged.
Get Started Today

Tell us about your project, and our scientific team will help evaluate your needs and confirm eligibility.

Claim Your Discount Now
Or contact us at: animal-service@cyagen.com
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research